Literature DB >> 30244535

Early restenosis of resorbable magnesium scaffolds: Optical coherence tomography findings.

Marcos García-Guimaraes1,2, Paula Antuña1,2, Javier Cuesta1,2, Fernando Alfonso1,2.   

Abstract

Resorbable Magnesium Scaffolds (RMS) represent an interesting alternative to current drug-eluting stents. Current data from clinical trials seems to confirm good performance of these new devices with low rates of late device failure. Little is known about mechanisms leading to RMS failure. Herein, we present the first description of an early RMS in-scaffold restenosis. Optical coherence tomography (OCT) analysis at implantation detected acute non-severe malapposition and underexpansion as main promoters of RMS failure. OCT during in-scaffold restenosis intervention confirmed early severe neointimal proliferation and RMS late recoil and dismantling as the main mechanisms of device failure. We hypothesize that the fast resorption process of RMS may lead to an early loss of radial strength, that could favor late recoil, acquired underexpansion, device dismantling and might interact with distribution of sirolimus. This case also illustrates that OCT is pivotal to unravel both acute and acquired mechanisms related to RMS failure.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  coronary artery disease; optical coherence tomography; stent restenosis

Mesh:

Substances:

Year:  2018        PMID: 30244535     DOI: 10.1002/ccd.27871

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  1 in total

1.  BIOSOLVE-IV-registry: Safety and performance of the Magmaris scaffold: 12-month outcomes of the first cohort of 1,075 patients.

Authors:  Stefan Verheye; Adrian Wlodarczak; Piero Montorsi; Jan Torzewski; Johan Bennett; Michael Haude; Gregory Starmer; Thomas Buck; Marcus Wiemer; Amin A B Nuruddin; Bryan P-Y Yan; Michael K-Y Lee
Journal:  Catheter Cardiovasc Interv       Date:  2020-09-03       Impact factor: 2.692

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.